Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: GlobalData
Provider: New Constructs, LLC

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endologix Inc Issues FY 2013 Guidance In Line With Analysts' Estimates

Wednesday, 27 Feb 2013 04:45pm EST 

Endologix Inc announced that for fiscal 2013, it expects revenue to be in the range of $126 million to $133 million, GAAP loss of ($0.14) to ($0.17) per share and an adjusted EBITDA (non-GAAP) of $0.01 to $0.05 per share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $131 million and EPS of $(0.04) for fiscal 2013. 

Company Quote

-0.04 -0.26%
1:21pm EST